OpenAlex
PricingAboutJobs
Log inGet started
Work

EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC

HTML

Year: 2021
Type: article
Source: Clinical Lung Cancer
DOI: 10.1016/j.cllc.2021.10.002
Authors: Fred R. Hirsch, Mary W. Redman, James Moon, Francesco Agustoni, Roy S. Herbst, Thomas J. Semrad, Marileila Varella-Garcia, Chris J. Rivard, Karen Kelly, David R. Gandara, Philip C. Mack
Institutions: Mount Sinai Health System, Tisch Cancer Institute, University of Colorado Anschutz, Fred Hutch Cancer Center, Policlinico San Matteo Fondazione, Yale Cancer Center, University of California, Davis
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: green

Funders: Eli Lilly and Company, National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences
Awards: UCDCCC NCTN U10 Program, SWOG Network Group Operations Center of the NCTN, UCDCCC NCTN UG1 PROGRAM, SWOG Statistics and Data Management Center, Cancer Center Support Grant P30, Yale Clinical and Translational Science Award
OpenAlex ID: W3205352786
FWCI: 1.549
Cites: 26
Cited by: 15
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms